GOVX: GeoVax Labs, Inc. Stock

by  •  • Comments Off on GOVX: GeoVax Labs, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.37
Enterprise Value ($M) -3.08
Book Value ($M) 5.76
Book Value / Share 2.50
Price / Book 0.58
NCAV ($M) 4.37
NCAV / Share 1.89
Price / NCAV 0.77

Profitability (mra)
Return on Invested Capital (ROIC) -4.51
Return on Assets (ROA) -0.95
Return on Equity (ROE) -1.14

Liquidity (mrq)
Quick Ratio 2.24
Current Ratio 2.24

Balance Sheet (mrq) ($M)
Current Assets 7.89
Assets 9.28
Liabilities 3.52
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -26.74
Net Income -25.97
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -25.17
Cash from Investing -0.05
Cash from Financing 4.06

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Armistice Capital, Llc 9.99 1,551.56

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-11 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 47,033 141,240 33.30
2024-05-02 1,846 2,516 73.37
2024-05-01 4,332 3,928 110.29
2024-04-30 1,379 2,673 51.59
2024-04-29 1,703 2,439 69.82

(click for more detail)

Similar Companies
GLTO – Galecto, Inc. GNLX – Genelux Corporation
GNPX – Genprex, Inc. GTBP – GT Biopharma, Inc.
GYRE – Gyre Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io